相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
Sahil Mittal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment
Stefano Ballestri et al.
HEPATOLOGY RESEARCH (2016)
The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population
Moon Hee Yang et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
Stefano Ballestri et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2016)
Impact of Apolipoprotein B on Hepatosteatosis in a Population Infected with Hepatitis C Virus: A Cross-Sectional Observational Study
Ming-Shyan Lin et al.
OBESITY FACTS (2016)
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Amedeo Lonardo et al.
DIGESTIVE AND LIVER DISEASE (2015)
Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds
Chengfu Xu et al.
JOURNAL OF HEPATOLOGY (2015)
Apolipoprotein B Is Related to Metabolic Syndrome Independently of Low Density Lipoprotein Cholesterol in Patients with Type 2 Diabetes
Younghyup Lim et al.
ENDOCRINOLOGY AND METABOLISM (2015)
Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia
Mathilde Di Filippo et al.
JOURNAL OF HEPATOLOGY (2014)
Non-alcoholic fatty liver disease
Naveed Sattar et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai Study
Chengfu Xu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Association of apolipoprotein B and incidence of metabolic syndrome in Korean men: A 5-years' follow-up study
Jae-Hong Ryoo et al.
ATHEROSCLEROSIS (2013)
The regulation of ApoB metabolism by insulin
Mary E. Haas et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
The association between insulin and low-density lipoprotein receptors
Gopalakrishnan Ramakrishnan et al.
DIABETES & VASCULAR DISEASE RESEARCH (2012)
Elevated ApoB serum levels strongly predict early cardiovascular events
Bruna Gigante et al.
HEART (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism
Alanna Strong et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice
Ding Ai et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease
Chaohui Yu et al.
JOURNAL OF HEPATOLOGY (2012)
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD
Stefano Ballestri et al.
LIVER INTERNATIONAL (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Association of Lipid and Lipoprotein Profiles with Future Development of Type 2 Diabetes in Nondiabetic Korean Subjects: A 4-Year Retrospective, Longitudinal Study
Mi Hae Seo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010
Jian Gao Fan et al.
JOURNAL OF DIGESTIVE DISEASES (2011)
Reduction in serum apoB is associated with reduced inflammation and insulin resistance in post-menopausal women: A MONET study
May Faraj et al.
ATHEROSCLEROSIS (2010)
Apolipoprotein B100 biogenesis: a complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly
Angela C. Rutledge et al.
BIOCHEMISTRY AND CELL BIOLOGY (2010)
Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk
S. Holewijn et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Giovanni Targher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment
M. Andrikoula et al.
DIABETES OBESITY & METABOLISM (2008)
The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation
Masahide Hamaguchi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation
A. Onat et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Diagnostic value of ultrasonographic examination for nonalcoholic steatohepatitis in morbidly obese patients undergoing laparoscopic bariatric surgery
Ren-Jow Liang et al.
OBESITY SURGERY (2007)
Review: The role of insulin resistance in nonalcoholic fatty liver disease
Kristina M. Utzschneider et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women
M. Faraj et al.
DIABETOLOGIA (2006)
The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence
G Walldius et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Hepatic steatosis and insulin resistance: Does etiology make a difference?
A Lonardo et al.
JOURNAL OF HEPATOLOGY (2006)
分享论文
